Applied Therapeutics | SC 13G:超过5%持股股东披露文件-Morgan Stanley(8.6%),Morgan Stanley Capital Services LLC(7.0%)
Applied Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(6.0%)
Applied Therapeutics | 4:持股变动声明-高管 Perfetti Riccardo
Applied Therapeutics | 4:持股变动声明-高管 Funtleyder Leslie D.
Applied Therapeutics | 4:持股变动声明-高管 Shendelman Shoshana
Applied Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Shoshana Shendelman(6.6%)
Applied Therapeutics | 4:持股变动声明-高管 Shendelman Shoshana
Applied Therapeutics | 4:持股变动声明-高管 Perfetti Riccardo
Applied Therapeutics | 4:持股变动声明-高管 Funtleyder Leslie D.
Applied Therapeutics | 4:持股变动声明-董事 Kanter Stacy J.
Applied Therapeutics | 4:持股变动声明-董事 SKYLER JAY S
Applied Therapeutics | 4:持股变动声明-董事 MARCUS JOEL S
Applied Therapeutics | 4:持股变动声明-董事 Lerner Teena
Applied Therapeutics | 4:持股变动声明-股东 ALEXANDRIA REAL ESTATE EQUITIES, INC.
Applied Therapeutics | 4:持股变动声明-高管 Hooks Corwin Dale
Applied Therapeutics | 3:首次持股声明-高管 Hooks Corwin Dale
Applied Therapeutics | 4:持股变动声明-高管 Shendelman Shoshana
Applied Therapeutics | 4:持股变动声明-高管 Perfetti Riccardo
Applied Therapeutics | 4:持股变动声明-高管 Hansard Adam
Applied Therapeutics | 4:持股变动声明-高管 Funtleyder Leslie D.
暂无数据
暂无数据